Synthesis and characterization of functional multicomponent nanosized gallium chelated gold crystals

Chemical Communications

Volumn 50, Issue 25, 2014, Pages 3281-3284

  Zambre, Ajit ^a   Silva, Francisco ^b   Upendran, Anandhi ^c   Afrasiabi, Zahra ^d   Xin, Yan ^e   Paulo, António ^b   Kannan, Raghuraman ^a,c  

^a University of Missouri   (United States)

^b INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^c UNIVERSITY OF MISSOURI   (United States)

^d LINCOLN UNIVERSITY   (United States)

^e FLORIDA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM; GOLD NANOPARTICLE; METAL COMPLEX; NANOCRYSTAL; PENTETIC ACID;

ARTICLE; CHELATION; CONJUGATION; CYTOTOXICITY; ELECTRON BEAM; ELECTRON ENERGY LOSS SPECTROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSICAL CHEMISTRY; SCANNING TRANSMISSION ELECTRON MICROSCOPY; SURFACE PROPERTY; SYNTHESIS; ZETA POTENTIAL;

CELL LINE, TUMOR; CELL SURVIVAL; CHELATING AGENTS; GALLIUM; GOLD; HUMANS; METAL NANOPARTICLES; PENTETIC ACID;

EID: 84896855427     PISSN: 13597345     EISSN: 1364548X     Source Type: Journal    
DOI: 10.1039/c3cc47308b     Document Type: Article

References (17)

1. D. A. Giljohann, D. S. Seferos, W. L. Daniel, M. D. Massich, P. C. Patel, C. A. Mirkin Gold nanoparticles for biology and medicine Angew. Chem., Int. Ed 2010 49 19 3280-3294
2. M. Ferrari Cancer nanotechnology: opportunities and challenges Nat. Rev. Cancer 2005 5 3 161-171
3. D. Wang, Y. Li Bimetallic nanocrystals: liquid-phase synthesis and catalytic applications Adv. Mater. 2011 23 9 1044-1060
4. N. Desai Challenges in development of nanoparticle-based therapeutics AAPS J. 2012 14 2 282-295
5. A. C. Eifler, C. S. Thaxton Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study Methods Mol. Biol. 2011 726 325-338
6. C. R. Chitambar Medical applications and toxicities of gallium compounds Int. J. Environ. Res. Public Health 2010 7 5 2337-2361
7. P. Samara, H. Kalbacher, K. Ioannou et al., Development of an ELISA for the quantification of the C-terminal decapeptide prothymosin alpha(100-109) in sera of mice infected with bacteria J. Immunol. Methods 2013 395 1-2 54-62
8. C. Alric, J. Taleb, G. Le Duc et al., Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging J. Am. Chem. Soc. 2008 130 18 5908-5915
9. P.-J. Debouttière, S. Roux, F. Vocanson, C. Billotey, O. Beuf, A. Favre-Réguillon, Y. Lin, S. Pellet-Rostaing, R. Lamartine, P. Perriat, O. Tillement Design of Gold Nanoparticles for Magnetic Resonance Imaging Adv. Funct. Mater. 2006 16 2330-2339
10. C. Alric, I. Miladi, D. Kryza et al., The biodistribution of gold nanoparticles designed for renal clearance Nanoscale 2013 5 13 5930-5939
11. M. K. Moi, S. J. DeNardo, C. F. Meares Stable bifunctional chelates of metals used in radiotherapy Cancer Res. 1990 50 3 suppl 789s-793s
12. N. Chanda, V. Kattumuri, R. Shukla et al., Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity Proc. Natl. Acad. Sci. U. S. A. 2010 107 19 8760-8765
13. N. Chanda, R. Shukla, K. V. Katti, R. Kannan Gastrin releasing protein receptor specific gold nanorods: breast and prostate tumor avid nanovectors for molecular imaging Nano Lett. 2009 9 5 1798-1805
14. Z. W. Wang, R. E. Palmer Mass spectrometry and dynamics of gold adatoms observed on the surface of size-selected Au nanoclusters Nano Lett. 2012 12 1 91-95
15. M. M. Yazdanpanah, S. A. Harfenist, R. W. Cohn Gallium-driven assembly of gold nanowire networks Appl. Phys. Lett. 2004 85 9 1592-1594
16. V. G. Weizer, N. S. Fatemi The interaction of gold with gallium arsenide J. Appl. Phys. 1988 64 9 4618-4623
17. E. E. Connor, J. Mwamuka, A. Gole, C. J. Murphy, M. D. Wyatt Small 2005 1 325-327